FOV2304
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FOV2304, covering 2012-08-23 to 2012-08-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy [Phase 2]